No conclusions can be made.The patient's attorney alleges adverse patient outcome associated with the hernia mesh used to treat the patient including hernia recurrence, infection, fistula and subsequent surgical intervention for mesh removal.The instructions-for-use (ifu) supplied with the device lists fistula and hernia recurrence as possible complications.No lot number has been provided; therefore, a review of the manufacturing records is not possible.In regards to the infection, the warnings section of the ifu states "if an infection develops, treat the infection aggressively.The prosthesis may not have to be removed.An unresolved infection, however, may require removal of the prosthesis." should additional information be provided, a supplemental emdr will be submitted.
|
Attorney alleges that the patient underwent an incisional hernia repair surgery on (b)(6) 2013 and a bard/davol composix mesh was implanted.It is alleged that further to the implantation of the product, the patient suffered the development of fatigue, polydipsia, chronic infection, chronic fistula, chronic pain, fluid accumulation in the abdominal wall, and hernia recurrence.The patient experienced severe pain and suffering, and necessitating a partial mesh removal and revision surgery on (b)(6) 2013.It is alleged that the patient has suffered injuries, losses and damages resulting from numerous defects in the product that create an unreasonably high risk of injury with severe permanent adverse health consequences.It is also alleged the patient was treated with a course of hospitalization, diagnostic imaging, revision surgery, serum testing, antibiotics, analgesics and rest.Attorney alleges that the patient will require further invasive repair surgery, physiotherapy, rehabilitation and will continue to require other forms of medical care.It is also alleged that the device was defective.
|